Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Liquid Biopsies 2019

Liquid Biopsies 2019



Conference Chairman

Lucia R. Languino

Lucia R. Languino
Professor of Cancer Biology, Thomas Jefferson University

Keynote Speakers


Massimo Cristofanilli
Professor of Medicine, Associate Director of Translational Research and Precision Medicine, Robert H Lurie Comprehensive Cancer Center, Northwestern University


Yves A. DeClerck
Professor of Pediatrics and Biochemistry & Molecular Medicine, Children’s Hospital Los Angeles, University of Southern California


Dolores Di Vizio
Professor, Cedars Sinai Medical Center


Sam Hanash
Director, McCombs Institute for Cancer Detection and Treatment, University of Texas MD Anderson Cancer Center


David Hoon
Professor, Director Department of Translational Molecular Medicine, John Wayne Cancer Institute


Jennifer Jones
Staff Clinician, Molecular Immunogenetics & Vaccine Research Section, National Cancer Institute (NCI)


Cheng-Ho Jimmy Lin
Chief Scientific Officer, Oncology, Natera


John Nolan
Professor, The Scintillon Institute


Balaji Panchapakesan
Professor, Department of Mechanical Engineering, Worcester Polytechnic Institute (WPI)


Erkki Ruoslahti
Distinguished Professor and Former President, Sanford Burnham Prebys Medical Discovery Institute


Steve Soper
Foundation Distinguished Professor, Director, Center of BioModular Multi-scale System for Precision Medicine, The University of Kansas, Adjunct Professor, Ulsan National Institute of Science & Technology


Shan Wang
Leland T. Edwards Professor in the School of Engineering, Stanford University

Overview

SelectBIO Liquid Biopsies 2019 focuses primarily on biofluid-based molecular biomarkers, such as circulating tumor DNA (ctDNA) as well as circulating tumor cells (CTCs), and protein-based circulating biomarkers.  There is much interest in the potential of ctDNA for developing biological fluid-based biopsies (such as using plasma, urine, or other biofluids) and the presenters in this track bring together the most up-to-date information and current state-of-the-field.

The conference further explores the potential of various minimally-invasive circulating biomarker classes, such as circulating-free DNA (cfDNA), CTCs, and Extracellular Vesicles (EVs), for development of novel diagnostics for early disease screening, patient monitoring and minimal residual disease detection.

This conference is held concurrently with the Circulating Biomarkers 2019 Conference enabling delegates full access to the scientific presentations in both conferences, co-located exhibit hall, and extensive networking opportunities.



Information and Local Registration Facilities for this Conference are also available in:

Japanese  |  Korean  |  Chinese (Simplified)  |  Chinese (Traditional)

Agenda Topics

  • Circulating Tumor Cells (CTCs): Potential for Development of Liquid Biopsies
  • Circulating Tumor DNA (ctDNA): Potential for Development of Liquid Biopsies
    • Emerging Technologies and Emerging Companies Showcase
    • Technology Platforms for Interrogation
  • Extracellular Nucleic Acids in the Circulation: Circulating Free DNA, Extracellular RNAs and Circulating microRNAs/Long Non-Coding RNAs
  • Microfluidics Platforms for Diagnostics Development
  • US vs. EU vs. Asia/Pacific Regulatory Landscape for Liquid Biopsies

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865

Distinguished Faculty

Hatim Husain, Assistant Professor of Medicine, University of California San Diego
Yazhen Zhu, Assistant Project Scientist, David Geffen School of Medicine at UCLA
Sergio Barberan-Soler, Director of Sequencing Technologies, Somagenics, Inc
Lauren Leiman, Executive Director, Blood Profiling Atlas in Cancer (BloodPAC)
Brian Dougherty, Executive Director, Translational Genomics, Oncology IMED, AstraZeneca R&D
Kang Zhang, Founding Director, Institute for Genomic Medicine, University of California-San Diego
Kai Wang, Principal Scientist, Institute for Systems Biology
Jasmine Zhou, Professor, University of California-Los Angeles
Kun Zhang, Professor, Department of Bioengineering, University of California San Diego
Alexander Johnson-Buck, Research Assistant Professor, University of Michigan
Rachel Tam, Senior Scientific Researcher, Oncology Biomarker Development, Genentech
Jean-François Martini, Sr. Director, Translational Oncology, Immuno-Oncology, Early Development, Pfizer
Bernhard Zimmermann, Vice President of Research and Development, Natera


Corporate SponsorsWeb SponsorsOffical Journal PartnerNetworking
Drug Discovery WorldU-Networks